Cancer
patients could soon be donning a personalized protection shield giving them an
extra level of armor against radioactive toxicity while undergoing radiation
therapy. More than 200,000 patients in the United States report injuries to
healthy tissue from radiation exposure annually. A large portion of the damage occurs
in the mouth and gastrointestinal tract leading to oral mucositis, esophagitis,
and proctitis.
A team of
researchers published a study in Advanced Science that outlines the
personalized 3D-printed device that shields radiation from patients. The
proof-of-concept was designed by the Brigham and Women’s Hospital, Dana-Farber
Cancer Institute, Massachusetts General Hospital (MGH), and the Massachusetts
Institute of Technology (MIT.)
James Byrne,
M.D., Ph. D., a postdoctoral researcher at Brigham and Women’s and MIT; senior
radiation oncology resident physician at Brigham and Women’s; MGH; and the
Dana-Farber Cancer Institute, said their testing showed “Promising results.
When we treat patients with radiation, we do our best to minimize the area of
healthy tissue that receives radiation and break up treatment into small doses,
but it’s a fine balance. We want to administer the most dose we can to shrink
the tumor without causing damage to healthy tissue. Our goal through this
project was to find an innovative solution that could offer personalized
protection for patients.”
To develop
the shield, several types of solid and liquid materials were used. Eventually,
substances that block gamma and X-rays were chosen to reduce radiation
backscatter. Custom-made designs from CT scans were produced from 3D printers.
Rats and pigs were used to test the devices, focusing on whether they impacted
the mouth and gastrointestinal tracts. Patients commonly experience side
effects of radiation in the esophagus, small intestine, or gastrointestinal
tract.
The
encouraging results shows that the 3D shield successfully protects healthy
tissue in the mouth and rectum of rats. In humans, the device could reduce mouth
radiation by 30 percent for head and neck cancer patients. A 15-percent drop in
radiation exposure could also be noted for prostate cancer patients without any
dose reaction to the tumor.
Acceletronics is an industry leader in delivering the best equipment
performance and service reliability from CT Scanners and Linear Accelerators
across all major brands and models. Call 610-524-3300 or visit our website: https://www.acceletronics.com.
Written by the digital marketing staff at Creative
Programs & Systems: www.cpsmi.com.
No comments:
Post a Comment